SCHEMBL10102507

SCHEMBL10102507

Cc1cc(O)c(CN2CCN(Cc3c(O)cc(O)cc3O)CCN(Cc3c(O)cc(O)cc3O)CCN(Cc3c(O)cc(C(C)(C)C)cc3O)CC2)c(O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 1/20 0.40
▸ GABRB2 P47870 1/20 0.40
▸ TSHR P16473 3/20 0.39
▸ ALDH1A1 P00352 9/20 0.38
▸ KDM4E B2RXH2 4/20 0.38
▸ MAPT P10636 3/20 0.38
▸ GAA P10253 4/20 0.35
▸ HPGD P15428 3/20 0.35
▸ LMNA P02545 2/20 0.35
▸ POLB P06746 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ CACNA1B Q00975 1/20 0.35
▸ ALOX15 P16050 3/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ OPRD1 P41143 1/20 0.34
▸ PARP1 P09874 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16298959 0.89 ALDH1A1 (0.39) TSHRALDH1A1KDM4EMAPTHPGD
SCHEMBL10102506 0.78 TSHR (0.41) TSHRALDH1A1KDM4EMAPTLMNA
SCHEMBL16298958 0.72 ALOX15 (0.39) ALDH1A1KDM4EMAPTHPGDLMNA
SCHEMBL10699916 0.68 HTR1D (0.46) TSHRALDH1A1KDM4EMAPTGAA
SCHEMBL29042657 0.67 ALDH1A1 (0.39) GABRA1GABRB2ALDH1A1MAPTGAA
SCHEMBL3359223 0.66 GABRA1 (0.71) GABRA1GABRB2TSHRALDH1A1MAPT
SCHEMBL18775237 0.66 ALDH1A1 (0.58) TSHRALDH1A1KDM4EMAPTGAA
SCHEMBL10425103 0.65 LMNA (0.46) TSHRMAPTHPGDLMNAPOLB
SCHEMBL3976297 0.65 TSHR (0.76) TSHRALDH1A1KDM4EGAAHPGD
SCHEMBL10705219 0.65 HTR1D (0.49) TSHRKDM4EMAPTLMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119103-B2 Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates MALLINCKRODT LLC (US) 2012-02-21 — — US disclosed
US-20090082324-A1 Bifunctional Resorcinol, Thioresorcinol, and Dithioresorcinol Derivative Metal Chelating Conjugates INFACARE PHARMACEUTICAL CORPORATION 2009-03-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082324-A1 Bifunctional Resorcinol, Thioresorcinol, and Dithioresorcinol Derivative Metal Chelating Conjugates SPR, QDPR, SLC40A1 GABRA1 4086/4885GABRB2 4376/4885TSHR 209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback